The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk ( NVO) and Eli Lilly ( LLY) by introducing GLP-1 pills.

Boasted as being a “breakthrough capsule formula designed to boost GLP-1 hormone levels, reduce hunger and cravings and ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...

"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical professional," one expert told Newsweek.

Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...

GLP-1 medicines like Ozempic, Wegovy, and Zepbound – popular across the US, help you shed pounds, but only if taken properly.

Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...